CATALOGO DEI PRODOTTI DELLA RICERCA

ADAMI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.980
AS - Asia 2.627
EU - Europa 2.400
SA - Sud America 393
AF - Africa 57
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.465
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.934
SG - Singapore 1.034
CN - Cina 847
GB - Regno Unito 475
IT - Italia 363
RU - Federazione Russa 359
BR - Brasile 351
HK - Hong Kong 325
DE - Germania 301
SE - Svezia 226
FR - Francia 224
IE - Irlanda 214
IN - India 130
KR - Corea 105
FI - Finlandia 96
JP - Giappone 45
VN - Vietnam 29
NL - Olanda 28
CA - Canada 27
TG - Togo 27
TR - Turchia 23
AT - Austria 22
UA - Ucraina 20
BD - Bangladesh 16
ZA - Sudafrica 16
ID - Indonesia 15
IQ - Iraq 13
MX - Messico 13
AR - Argentina 10
PL - Polonia 9
BE - Belgio 8
ES - Italia 8
VE - Venezuela 8
PT - Portogallo 7
UZ - Uzbekistan 7
CH - Svizzera 6
CO - Colombia 6
EC - Ecuador 6
GR - Grecia 6
IR - Iran 6
AU - Australia 4
CL - Cile 4
CZ - Repubblica Ceca 4
PK - Pakistan 4
AL - Albania 3
KG - Kirghizistan 3
KW - Kuwait 3
LV - Lettonia 3
PY - Paraguay 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
HR - Croazia 2
JO - Giordania 2
MA - Marocco 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SI - Slovenia 2
SN - Senegal 2
A1 - Anonimo 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CD - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GF - Guiana Francese 1
GN - Guinea 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
MY - Malesia 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SV - El Salvador 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.465
Salva come PNG Salva come JPEG
Città #
Dallas 563
Chandler 488
Singapore 449
Southend 448
Hong Kong 319
Ashburn 209
Dublin 209
Beijing 128
Jacksonville 101
Redmond 90
Wilmington 78
Lawrence 74
Princeton 74
New York 71
Bologna 68
Verona 62
Ann Arbor 61
Jinan 60
Munich 59
Helsinki 54
Shenyang 54
The Dalles 53
Hyderabad 47
Nanjing 46
Sindelfingen 46
Tokyo 44
Seattle 37
Los Angeles 35
Woodbridge 35
Hebei 34
Columbus 32
São Paulo 30
Tianjin 28
Lomé 27
Washington 27
Zhengzhou 27
Hangzhou 23
Turku 23
Guangzhou 22
Santa Clara 22
Taiyuan 22
Changsha 21
Haikou 21
Moscow 19
Ningbo 19
San Francisco 19
Houston 18
Milan 18
Nanchang 18
Rome 18
Dongguan 16
Fairfield 15
Jiaxing 15
Redwood City 15
Brooklyn 14
Taizhou 13
Jakarta 12
Rio de Janeiro 12
Council Bluffs 11
Norwalk 11
Seoul 11
Venice 11
London 10
Vienna 10
Miami 9
Warsaw 9
Boston 8
Brasília 8
Campinas 8
Chicago 8
Falls Church 8
Fuzhou 8
Johannesburg 8
Amsterdam 7
Brussels 7
Dearborn 7
Falkenstein 7
Mexico City 7
Tashkent 7
Atlanta 6
Ho Chi Minh City 6
Lanzhou 6
Nuremberg 6
Roubaix 6
Belo Horizonte 5
Boydton 5
Charlotte 5
Chennai 5
Dong Ket 5
Düsseldorf 5
Frankfurt am Main 5
Goiânia 5
Guarulhos 5
Kent 5
Lappeenranta 5
Manchester 5
Montreal 5
Naples 5
Ribeirão Preto 5
Shanghai 5
Totale 4.952
Salva come PNG Salva come JPEG
Nome #
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 174
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 168
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 142
Anti-CCP antibodies and bone 142
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 141
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 140
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 137
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 134
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 131
Could γ\δ T-cells explain zoledronic acid adverse events? 120
Safety issues and adverse reactions with osteoporosis management 119
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 118
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 115
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 114
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 114
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 113
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 110
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 108
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 106
The obesity paradox and osteoporosis 104
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 103
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 102
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 102
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 101
Rheumatoid arthritis, γδ T cells and bisphosphonates 98
Association between environmental air pollution and rheumatoid arthritis flares 98
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 96
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 94
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 92
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 92
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 90
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 90
Calcium and vitamin D supplementation: when and why 90
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 90
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 89
Osteoporosis in Rheumatic Diseases 85
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 85
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 83
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 83
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 82
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 82
Gender disparity in authorship of guidelines and recommendations in rheumatology 81
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 81
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 81
Correction to: The obesity paradox and osteoporosis 79
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 78
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 78
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 77
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 76
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 75
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 73
Association between acute exposure to environmental air pollution and fragility hip fractures 73
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 73
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 72
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 72
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 71
A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study 70
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 69
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 68
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 68
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3 68
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 65
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 65
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 64
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 62
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 62
A Prospective Open-Label Observational Study of a Buffered Soluble 70{\hspace{0.167em}}mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The {GastroPASS} Study 62
Glucocorticoid-induced osteoporosis: 2019 concise clinical review 61
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 60
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 59
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 59
Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial 59
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis 59
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 58
Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low-Dose Glucocorticoids and Prevention by Anti-Osteoporosis Medications 57
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 55
Changes in bone turnover markers and bone modulators during abatacept treatment 53
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 53
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 52
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 51
Cardiovascular Safety of Romosozumab: New Insights from Postmenopausal Women with Chronic Kidney Disease 51
Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart 50
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 49
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 49
Bone health status evaluation in men by means of REMS technology 48
Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study 48
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 46
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal 46
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 44
Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis 44
Glucocorticoid-induced osteoporosis update 44
Balancing benefits and risks in the era of biologics 43
Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database 42
Pragmatic Clinical Trials in Osteoporosis 42
Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot study 42
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach 41
Regulation of bone mass in inflammatory diseases 41
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis 41
Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on 'Diagnosis, risk stratification, and continuity of care of fragility fractures' based on a systematic literature review 39
Machine learning to characterize bone biomarkers profile in rheumatoid arthritis 38
Totale 7.964
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.967
article - articoli 39.851
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 116
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.934
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021428 0 0 22 114 58 44 40 5 52 5 55 33
2021/2022579 59 129 8 20 30 21 15 34 56 20 27 160
2022/20231.499 88 151 118 286 127 345 15 68 170 36 74 21
2023/2024982 40 70 89 125 80 202 54 44 30 43 151 54
2024/20252.632 111 132 104 409 160 79 136 103 402 318 231 447
2025/20261.318 538 391 389 0 0 0 0 0 0 0 0 0
Totale 8.705